Oncolytics Biotech Inc

Research Oncolytics Biotech Inc (ONCY) on Bullrun: market cap USD 114.76M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerONCY
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 114.76M
• Financial periodFY2025
• Net income-USD 28.76M
• Free cash flow-USD 20.12M

Valuation Snapshot

latest market cap is USD 114.76M.

About Oncolytics Biotech Inc

Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments. The company develops pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of gastrointestinal (“GI”) tumors, metastatic colorectal cancer, anal cancer, and metastatic pancreatic cancer. It has an agreement with Roche Holding AG to supply its immune checkpoint inhibitors, atezolizumab, for use in its ongoing sponsored studies.

Frequently asked questions

What is Oncolytics Biotech Inc's market cap?

Oncolytics Biotech Inc's market capitalization is USD 114.76M.

What does Oncolytics Biotech Inc do?

Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments.